ZNF545 Inhibitors
Chemical inhibitors of protein ZNF545 utilize various mechanisms to inhibit its functional activity. Staurosporine, a well-known protein kinase C inhibitor, disrupts signaling pathways that are essential for the phosphorylation of transcription factors. Since these transcription factors can regulate the activity of ZNF545, the action of staurosporine can lead to a reduction in ZNF545 activity. Similarly, LY294002 and wortmannin, both phosphoinositide 3-kinase (PI3K) inhibitors, decrease Akt phosphorylation and activity. This reduction in Akt activity can lead to diminished activity of transcription factors that interact with ZNF545, thereby inhibiting its function. Rapamycin, an mTOR inhibitor, suppresses the activity of downstream effectors in the PI3K/Akt/mTOR pathway, which can alter the cellular growth conditions and indirectly affect the activity of ZNF545.
Further inhibitory effects are seen with SB203580 and SP600125, which are inhibitors of p38 MAP kinase and JNK pathway respectively. Both these kinases are involved in stress response pathways and can modulate transcription factor activities that regulate ZNF545. Inhibition of these kinases leads to changes in the phosphorylation states of transcription factors, which in turn affects ZNF545's role in gene expression. MEK inhibitors, PD98059 and U0126 prevent the activation of ERK, which is responsible for phosphorylating numerous substrates including transcription factors that may regulate ZNF545. PP2, an Src family kinase inhibitor, and PD168393, an irreversible inhibitor of EGFR tyrosine kinase, also contribute to the reduction in transcription factor activity, which in turn can inhibit the functional activity of ZNF545. Y-27632, a ROCK inhibitor, changes the organization of the actin cytoskeleton, which is critical for the transcriptional regulation within the cell and may indirectly influence the activity of ZNF545. Lastly, IKK-16, by inhibiting IKK in the NF-κB signaling pathway, can prevent the activation of NF-κB, a transcription factor that can regulate gene expression and subsequently inhibit ZNF545 activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent protein kinase C (PKC) inhibitor. PKC is involved in various signaling pathways that can lead to phosphorylation of transcription factors. By inhibiting PKC, staurosporine can prevent the phosphorylation and activation of transcription factors that may interact with or regulate ZNF545, resulting in its functional inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor. By inhibiting PI3K, LY294002 can reduce Akt phosphorylation and activity. Since Akt can phosphorylate and regulate various proteins including transcription factors, the inhibition of this pathway can result in a decrease in transcription factor activity, thus potentially inhibiting ZNF545's function in transcriptional regulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. mTOR is part of the PI3K/Akt/mTOR pathway, which is implicated in the regulation of protein synthesis and cell growth. By inhibiting mTOR, rapamycin can suppress the activity of downstream effectors that may indirectly inhibit the functional activity of ZNF545 by altering the cellular growth conditions that support its activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor. This kinase is involved in the stress response pathway and can influence the activity of various transcription factors. Inhibition of p38 MAPK can lead to altered transcription factor phosphorylation states and activities, potentially inhibiting ZNF545's role in gene expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is upstream of the ERK pathway. ERK is known to phosphorylate a wide range of substrates including transcription factors. By inhibiting MEK, PD98059 can prevent the activation of ERK and subsequent phosphorylation of transcription factors, which could inhibit the functional activity of ZNF545. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor, functioning similarly to PD98059. It prevents the activation of ERK and the downstream phosphorylation of transcription factors. By doing so, U0126 can indirectly inhibit the functional activity of ZNF545 by affecting the phosphorylation and activation status of transcription factors possibly interacting with ZNF545. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of the JNK pathway, which is involved in cellular stress responses and can modify transcription factor activities. By inhibiting JNK, SP600125 can prevent the phosphorylation of transcription factors that could be involved in the regulation of ZNF545's transcriptional activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor like LY294002. By inhibiting PI3K, wortmannin decreases Akt activity, which can lead to reduced activity of downstream transcription factors, potentially inhibiting the functional activity of ZNF545. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. Src kinases can affect various signaling pathways, including those that regulate transcription factors. By inhibiting Src kinases, PP2 can reduce the phosphorylation and activity of transcription factors, which may inhibit the functional activity of ZNF545. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor. ROCK can influence the organization of the actin cytoskeleton, which is crucial for various cellular processes including transcriptional regulation. By inhibiting ROCK, Y-27632 can alter cellular mechanics that may indirectly inhibit the functional activity of ZNF545 by affecting the cellular context in which ZNF545 operates. | ||||||